APO Research
Talk to an analyst

APO RESEARCH · REPORT

Direct-to-consumer Genetic Testing

Direct-to-consumer (DTC) genetic testing is a type of genetic test that is accessible directly to the consumer without having to go through a health care professional. Usually, to obtain a genetic test, health care professionals (such as doctors) acquire their patient's permission and then order the desired test. DTC genetic tests, however, allow consumers to bypass this process and order DNA tests themselves.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Direct-to-consumer (DTC) genetic testing is a type of genetic test that is accessible directly to the consumer without having to go through a health care professional. Usually, to obtain a genetic test, health care professionals (such as doctors) acquire their patient's permission and then order the desired test. DTC genetic tests, however, allow consumers to bypass this process and order DNA tests themselves.

Selected research

Market Outlook & Growth Opportunities

Global Direct-to-consumer Genetic Testing Market Outlook and Growth Opportunities 2026

20 December 2025212 pages

Choose your research edition.

Industry ResearchDirect-to-consumer Genetic Testing Industry Research Report 2026140 pages · $2,950 USDIndustry Growth & TrendsGlobal Direct-to-consumer Genetic Testing Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Direct-to-consumer Genetic Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Direct-to-consumer Genetic Testing Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Direct-to-consumer Genetic Testing Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

Direct-to-consumer (DTC) genetic testing is a type of genetic test that is accessible directly to the consumer without having to go through a health care professional. Usually, to obtain a genetic test, health care professionals (such as doctors) acquire their patient's permission and then order the desired test. DTC genetic tests, however, allow consumers to bypass this process and order DNA tests themselves.

Global direct-to-consumer genetic testing main players include 23andMe, MyHeritage, LabCorp, Myriad Genetics, Ancestry.com, etc., totally accounting for about 50% of the market. North America is the largest market, with a share over 60%. As for the types of products, it can be divided into diagnostic screening, preimplantation genetic diagnosis (PGD) and relationship testing. The most common product is relationship testing, with a share over 55%. In terms of applications, it is widely used in online and offline. Online is the largest application, holding a share over 68%.

This report provides an overview of the global Direct-to-consumer Genetic Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Direct-to-consumer Genetic Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Direct-to-consumer Genetic Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Direct-to-consumer Genetic Testing market.

Direct-to-consumer Genetic Testing Segment by Company

23andMe

MyHeritage

LabCorp

Myriad Genetics

Ancestry.com

Quest Diagnostics

Gene By Gene

DNA Diagnostics Center

Invitae

IntelliGenetics

Ambry Genetics

Living DNA

EasyDNA

Pathway Genomics

Centrillion Technology

Xcode

Color Genomics

Anglia DNA Services

African Ancestry

Canadian DNA Services

DNA Family Check

Alpha Biolaboratories

Test Me DNA

23 Mofang

Genetic Health

DNA Services of America

Shuwen Health Sciences

Mapmygenome

Full Genomes

Direct-to-consumer Genetic Testing Segment by Type

Diagnostic Screening

Preimplantation Genetic Diagnosis (PGD)

Relationship Testing

Direct-to-consumer Genetic Testing Segment by Application

Online Direct-to-consumer Genetic Testing

Offline Direct-to-consumer Genetic Testing

Direct-to-consumer Genetic Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Direct-to-consumer Genetic Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Direct-to-consumer Genetic Testing key companies, revenue, market share, and recent developments.

3. To split the Direct-to-consumer Genetic Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Direct-to-consumer Genetic Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Direct-to-consumer Genetic Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Direct-to-consumer Genetic Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Direct-to-consumer Genetic Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Direct-to-consumer Genetic Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Direct-to-consumer Genetic Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Direct-to-consumer Genetic Testing industry.

Chapter 3: Detailed analysis of Direct-to-consumer Genetic Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Direct-to-consumer Genetic Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Direct-to-consumer Genetic Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Direct-to-consumer Genetic Testing Industry Trends Table 2. Direct-to-consumer Genetic Testing Industry Drivers Table 3. Direct-to-consumer Genetic Testing Industry Opportunities and Challenges Table 4. Direct-to-consumer Genetic Testing Industry Restraints Table 5. Global Direct-to-consumer Genetic Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Direct-to-consumer Genetic Testing Revenue Share by Company (2021-2026) Table 7. Global Direct-to-consumer Genetic Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Direct-to-consumer Genetic Testing Key Company Manufacturing Base & Headquarters Table 9. Global Direct-to-consumer Genetic Testing Company, Product Type & Application Table 10. Global Direct-to-consumer Genetic Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Direct-to-consumer Genetic Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Diagnostic Screening Table 15. Significant Companies of Preimplantation Genetic Diagnosis (PGD) Table 16. Significant Companies of Relationship Testing Table 17. Global Direct-to-consumer Genetic Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Direct-to-consumer Genetic Testing Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Direct-to-consumer Genetic Testing Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Direct-to-consumer Genetic Testing Sales Value Share by Type (2021-2026) Table 21. Global Direct-to-consumer Genetic Testing Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Online Direct-to-consumer Genetic Testing Table 23. Significant Companies of Offline Direct-to-consumer Genetic Testing Table 24. Global Direct-to-consumer Genetic Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Direct-to-consumer Genetic Testing Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Direct-to-consumer Genetic Testing Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Direct-to-consumer Genetic Testing Sales Value Share by Application (2021-2026) Table 28. Global Direct-to-consumer Genetic Testing Sales Value Share by Application (2027-2032) Table 29. Global Direct-to-consumer Genetic Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Direct-to-consumer Genetic Testing Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Direct-to-consumer Genetic Testing Sales Value Share by Region (2021-2026) Table 32. Global Direct-to-consumer Genetic Testing Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Direct-to-consumer Genetic Testing Sales Value Share by Region (2027-2032) Table 34. Global Direct-to-consumer Genetic Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Direct-to-consumer Genetic Testing Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Direct-to-consumer Genetic Testing Sales Value Market Share by Country (2021-2026) Table 37. Global Direct-to-consumer Genetic Testing Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Direct-to-consumer Genetic Testing Sales Value Market Share by Country (2027-2032) Table 39. 23andMe Company Information Table 40. 23andMe Business Overview Table 41. 23andMe Direct-to-consumer Genetic Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. 23andMe Direct-to-consumer Genetic Testing Product Portfolio Table 43. 23andMe Recent Development Table 44. MyHeritage Company Information Table 45. MyHeritage Business Overview Table 46. MyHeritage Direct-to-consumer Genetic Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. MyHeritage Direct-to-consumer Genetic Testing Product Portfolio Table 48. MyHeritage Recent Development Table 49. LabCorp Company Information Table 50. LabCorp Business Overview Table 51. LabCorp Direct-to-consumer Genetic Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. LabCorp Direct-to-consumer Genetic Testing Product Portfolio Table 53. LabCorp Recent Development Table 54. Myriad Genetics Company Information Table 55. Myriad Genetics Business Overview Table 56. Myriad Genetics Direct-to-consumer Genetic Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Myriad Genetics Direct-to-consumer Genetic Testing Product Portfolio Table 58. Myriad Genetics Recent Development Table 59. Ancestry.com Company Information Table 60. Ancestry.com Business Overview Table 61. Ancestry.com Direct-to-consumer Genetic Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Ancestry.com Direct-to-consumer Genetic Testing Product Portfolio Table 63. Ancestry.com Recent Development Table 64. Quest Diagnostics Company Information Table 65. Quest Diagnostics Business Overview Table 66. Quest Diagnostics Direct-to-consumer Genetic Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Quest Diagnostics Direct-to-consumer Genetic Testing Product Portfolio Table 68. Quest Diagnostics Recent Development Table 69. Gene By Gene Company Information Table 70. Gene By Gene Business Overview Table 71. Gene By Gene Direct-to-consumer Genetic Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Gene By Gene Direct-to-consumer Genetic Testing Product Portfolio Table 73. Gene By Gene Recent Development Table 74. DNA Diagnostics Center Company Information Table 75. DNA Diagnostics Center Business Overview Table 76. DNA Diagnostics Center Direct-to-consumer Genetic Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. DNA Diagnostics Center Direct-to-consumer Genetic Testing Product Portfolio Table 78. DNA Diagnostics Center Recent Development Table 79. Invitae Company Information Table 80. Invitae Business Overview Table 81. Invitae Direct-to-consumer Genetic Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Invitae Direct-to-consumer Genetic Testing Product Portfolio Table 83. Invitae Recent Development Table 84. IntelliGenetics Company Information Table 85. IntelliGenetics Business Overview Table 86. IntelliGenetics Direct-to-consumer Genetic Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. IntelliGenetics Direct-to-consumer Genetic Testing Product Portfolio Table 88. IntelliGenetics Recent Development Table 89. Ambry Genetics Company Information Table 90. Ambry Genetics Business Overview Table 91. Ambry Genetics Direct-to-consumer Genetic Testing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 92. Ambry Genetics Direct-to-consumer Genetic Testing Product Portfolio Table 93. Ambry Genetics Recent Development Table 94. Living DNA Company Information Table 95. Living DNA Business Overview Table 96. Living DNA Direct-to-consumer Genetic Testing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 97. Living DNA Direct-to-consumer Genetic Testing Product Portfolio Table 98. Living DNA Recent Development Table 99. EasyDNA Company Information Table 100. EasyDNA Business Overview Table 101. EasyDNA Direct-to-consumer Genetic Testing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 102. EasyDNA Direct-to-consumer Genetic Testing Product Portfolio Table 103. EasyDNA Recent Development Table 104. Pathway Genomics Company Information Table 105. Pathway Genomics Business Overview Table 106. Pathway Genomics Direct-to-consumer Genetic Testing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 107. Pathway Genomics Direct-to-consumer Genetic Testing Product Portfolio Table 108. Pathway Genomics Recent Development Table 109. Centrillion Technology Company Information Table 110. Centrillion Technology Business Overview Table 111. Centrillion Technology Direct-to-consumer Genetic Testing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 112. Centrillion Technology Direct-to-consumer Genetic Testing Product Portfolio Table 113. Centrillion Technology Recent Development Table 114. Xcode Company Information Table 115. Xcode Business Overview Table 116. Xcode Direct-to-consumer Genetic Testing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 117. Xcode Direct-to-consumer Genetic Testing Product Portfolio Table 118. Xcode Recent Development Table 119. Color Genomics Company Information Table 120. Color Genomics Business Overview Table 121. Color Genomics Direct-to-consumer Genetic Testing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 122. Color Genomics Direct-to-consumer Genetic Testing Product Portfolio Table 123. Color Genomics Recent Development Table 124. Anglia DNA Services Company Information Table 125. Anglia DNA Services Business Overview Table 126. Anglia DNA Services Direct-to-consumer Genetic Testing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 127. Anglia DNA Services Direct-to-consumer Genetic Testing Product Portfolio Table 128. Anglia DNA Services Recent Development Table 129. African Ancestry Company Information Table 130. African Ancestry Business Overview Table 131. African Ancestry Direct-to-consumer Genetic Testing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 132. African Ancestry Direct-to-consumer Genetic Testing Product Portfolio Table 133. African Ancestry Recent Development Table 134. Canadian DNA Services Company Information Table 135. Canadian DNA Services Business Overview Table 136. Canadian DNA Services Direct-to-consumer Genetic Testing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 137. Canadian DNA Services Direct-to-consumer Genetic Testing Product Portfolio Table 138. Canadian DNA Services Recent Development Table 139. DNA Family Check Company Information Table 140. DNA Family Check Business Overview Table 141. DNA Family Check Direct-to-consumer Genetic Testing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 142. DNA Family Check Direct-to-consumer Genetic Testing Product Portfolio Table 143. DNA Family Check Recent Development Table 144. Alpha Biolaboratories Company Information Table 145. Alpha Biolaboratories Business Overview Table 146. Alpha Biolaboratories Direct-to-consumer Genetic Testing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 147. Alpha Biolaboratories Direct-to-consumer Genetic Testing Product Portfolio Table 148. Alpha Biolaboratories Recent Development Table 149. Test Me DNA Company Information Table 150. Test Me DNA Business Overview Table 151. Test Me DNA Direct-to-consumer Genetic Testing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 152. Test Me DNA Direct-to-consumer Genetic Testing Product Portfolio Table 153. Test Me DNA Recent Development Table 154. 23 Mofang Company Information Table 155. 23 Mofang Business Overview Table 156. 23 Mofang Direct-to-consumer Genetic Testing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 157. 23 Mofang Direct-to-consumer Genetic Testing Product Portfolio Table 158. 23 Mofang Recent Development Table 159. Genetic Health Company Information Table 160. Genetic Health Business Overview Table 161. Genetic Health Direct-to-consumer Genetic Testing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 162. Genetic Health Direct-to-consumer Genetic Testing Product Portfolio Table 163. Genetic Health Recent Development Table 164. DNA Services of America Company Information Table 165. DNA Services of America Business Overview Table 166. DNA Services of America Direct-to-consumer Genetic Testing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 167. DNA Services of America Direct-to-consumer Genetic Testing Product Portfolio Table 168. DNA Services of America Recent Development Table 169. Shuwen Health Sciences Company Information Table 170. Shuwen Health Sciences Business Overview Table 171. Shuwen Health Sciences Direct-to-consumer Genetic Testing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 172. Shuwen Health Sciences Direct-to-consumer Genetic Testing Product Portfolio Table 173. Shuwen Health Sciences Recent Development Table 174. Mapmygenome Company Information Table 175. Mapmygenome Business Overview Table 176. Mapmygenome Direct-to-consumer Genetic Testing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 177. Mapmygenome Direct-to-consumer Genetic Testing Product Portfolio Table 178. Mapmygenome Recent Development Table 179. Full Genomes Company Information Table 180. Full Genomes Business Overview Table 181. Full Genomes Direct-to-consumer Genetic Testing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 182. Full Genomes Direct-to-consumer Genetic Testing Product Portfolio Table 183. Full Genomes Recent Development Table 184. Research Programs/Design for This Report Table 185. Authors List of This Report Table 186. Secondary Sources Table 187. Primary Sources List of Figures Figure 1. Direct-to-consumer Genetic Testing Product Image Figure 2. Global Direct-to-consumer Genetic Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Direct-to-consumer Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Direct-to-consumer Genetic Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Diagnostic Screening Image Figure 8. Preimplantation Genetic Diagnosis (PGD) Image Figure 9. Relationship Testing Image Figure 10. Global Direct-to-consumer Genetic Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Direct-to-consumer Genetic Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Direct-to-consumer Genetic Testing Sales Value Share by Type (2021-2032) Figure 13. Online Direct-to-consumer Genetic Testing Image Figure 14. Offline Direct-to-consumer Genetic Testing Image Figure 15. Global Direct-to-consumer Genetic Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Direct-to-consumer Genetic Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Direct-to-consumer Genetic Testing Sales Value Share by Application (2021-2032) Figure 18. Global Direct-to-consumer Genetic Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Direct-to-consumer Genetic Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Direct-to-consumer Genetic Testing Sales Value (2021-2032) & (US$ Million) Figure 21. North America Direct-to-consumer Genetic Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Direct-to-consumer Genetic Testing Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Direct-to-consumer Genetic Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Direct-to-consumer Genetic Testing Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Direct-to-consumer Genetic Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Direct-to-consumer Genetic Testing Sales Value (2021-2032) & (US$ Million) Figure 27. South America Direct-to-consumer Genetic Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Direct-to-consumer Genetic Testing Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Direct-to-consumer Genetic Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Diagnostic Screening
  • Preimplantation Genetic Diagnosis (PGD)
  • Relationship Testing
Applications
  • Online Direct-to-consumer Genetic Testing
  • Offline Direct-to-consumer Genetic Testing
Companies covered
  • 23andMe
  • MyHeritage
  • LabCorp
  • Myriad Genetics
  • Ancestry.com
  • Quest Diagnostics
  • Gene By Gene
  • DNA Diagnostics Center
  • Invitae
  • IntelliGenetics
  • Ambry Genetics
  • Living DNA
  • EasyDNA
  • Pathway Genomics
  • Centrillion Technology
  • Xcode
  • Color Genomics
  • Anglia DNA Services
  • African Ancestry
  • Canadian DNA Services
  • DNA Family Check
  • Alpha Biolaboratories
  • Test Me DNA
  • 23 Mofang
  • Genetic Health
  • DNA Services of America
  • Shuwen Health Sciences
  • Mapmygenome
  • Full Genomes

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Direct-to-consumer Genetic Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Direct-to-consumer Genetic Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Direct-to-consumer Genetic Testing Market Dynamics
  1. 2.1 Direct-to-consumer Genetic Testing Industry Trends
  2. 2.2 Direct-to-consumer Genetic Testing Industry Drivers
  3. 2.3 Direct-to-consumer Genetic Testing Industry Opportunities and Challenges
  4. 2.4 Direct-to-consumer Genetic Testing Industry Restraints
3 Direct-to-consumer Genetic Testing Market by Company
  1. 3.1 Global Direct-to-consumer Genetic Testing Company Revenue Ranking in 2025
  2. 3.2 Global Direct-to-consumer Genetic Testing Revenue by Company (2021-2026)
  3. 3.3 Global Direct-to-consumer Genetic Testing Company Ranking (2024-2026)
  4. 3.4 Global Direct-to-consumer Genetic Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Direct-to-consumer Genetic Testing Company Product Type and Application
  6. 3.6 Global Direct-to-consumer Genetic Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Direct-to-consumer Genetic Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Direct-to-consumer Genetic Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Direct-to-consumer Genetic Testing Market by Type
  1. 4.1 Direct-to-consumer Genetic Testing Type Introduction
  2. 4.1.1 Diagnostic Screening
  3. 4.1.2 Preimplantation Genetic Diagnosis (PGD)
  4. 4.1.3 Relationship Testing
  5. 4.2 Global Direct-to-consumer Genetic Testing Sales Value by Type
  6. 4.2.1 Global Direct-to-consumer Genetic Testing Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Direct-to-consumer Genetic Testing Sales Value by Type (2021-2032)
  8. 4.2.3 Global Direct-to-consumer Genetic Testing Sales Value Share by Type (2021-2032)
5 Direct-to-consumer Genetic Testing Market by Application
  1. 5.1 Direct-to-consumer Genetic Testing Application Introduction
  2. 5.1.1 Online Direct-to-consumer Genetic Testing
  3. 5.1.2 Offline Direct-to-consumer Genetic Testing
  4. 5.2 Global Direct-to-consumer Genetic Testing Sales Value by Application
  5. 5.2.1 Global Direct-to-consumer Genetic Testing Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Direct-to-consumer Genetic Testing Sales Value by Application (2021-2032)
  7. 5.2.3 Global Direct-to-consumer Genetic Testing Sales Value Share by Application (2021-2032)
6 Direct-to-consumer Genetic Testing Regional Value Analysis
  1. 6.1 Global Direct-to-consumer Genetic Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Direct-to-consumer Genetic Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Direct-to-consumer Genetic Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Direct-to-consumer Genetic Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Direct-to-consumer Genetic Testing Sales Value (2021-2032)
  7. 6.3.2 North America Direct-to-consumer Genetic Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Direct-to-consumer Genetic Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Direct-to-consumer Genetic Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Direct-to-consumer Genetic Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Direct-to-consumer Genetic Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Direct-to-consumer Genetic Testing Sales Value (2021-2032)
  16. 6.6.2 South America Direct-to-consumer Genetic Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Direct-to-consumer Genetic Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Direct-to-consumer Genetic Testing Sales Value Share by Country, 2025 VS 2032
7 Direct-to-consumer Genetic Testing Country-level Value Analysis
  1. 7.1 Global Direct-to-consumer Genetic Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Direct-to-consumer Genetic Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Direct-to-consumer Genetic Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Direct-to-consumer Genetic Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Direct-to-consumer Genetic Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Direct-to-consumer Genetic Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Direct-to-consumer Genetic Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 23andMe
  2. 8.1.1 23andMe Company Information
  3. 8.1.2 23andMe Business Overview
  4. 8.1.3 23andMe Direct-to-consumer Genetic Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 23andMe Direct-to-consumer Genetic Testing Product Portfolio
  6. 8.1.5 23andMe Recent Developments
  7. 8.2 MyHeritage
  8. 8.2.1 MyHeritage Company Information
  9. 8.2.2 MyHeritage Business Overview
  10. 8.2.3 MyHeritage Direct-to-consumer Genetic Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 MyHeritage Direct-to-consumer Genetic Testing Product Portfolio
  12. 8.2.5 MyHeritage Recent Developments
  13. 8.3 LabCorp
  14. 8.3.1 LabCorp Company Information
  15. 8.3.2 LabCorp Business Overview
  16. 8.3.3 LabCorp Direct-to-consumer Genetic Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 LabCorp Direct-to-consumer Genetic Testing Product Portfolio
  18. 8.3.5 LabCorp Recent Developments
  19. 8.4 Myriad Genetics
  20. 8.4.1 Myriad Genetics Company Information
  21. 8.4.2 Myriad Genetics Business Overview
  22. 8.4.3 Myriad Genetics Direct-to-consumer Genetic Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Myriad Genetics Direct-to-consumer Genetic Testing Product Portfolio
  24. 8.4.5 Myriad Genetics Recent Developments
  25. 8.5 Ancestry.com
  26. 8.5.1 Ancestry.com Company Information
  27. 8.5.2 Ancestry.com Business Overview
  28. 8.5.3 Ancestry.com Direct-to-consumer Genetic Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Ancestry.com Direct-to-consumer Genetic Testing Product Portfolio
  30. 8.5.5 Ancestry.com Recent Developments
  31. 8.6 Quest Diagnostics
  32. 8.6.1 Quest Diagnostics Company Information
  33. 8.6.2 Quest Diagnostics Business Overview
  34. 8.6.3 Quest Diagnostics Direct-to-consumer Genetic Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Quest Diagnostics Direct-to-consumer Genetic Testing Product Portfolio
  36. 8.6.5 Quest Diagnostics Recent Developments
  37. 8.7 Gene By Gene
  38. 8.7.1 Gene By Gene Company Information
  39. 8.7.2 Gene By Gene Business Overview
  40. 8.7.3 Gene By Gene Direct-to-consumer Genetic Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Gene By Gene Direct-to-consumer Genetic Testing Product Portfolio
  42. 8.7.5 Gene By Gene Recent Developments
  43. 8.8 DNA Diagnostics Center
  44. 8.8.1 DNA Diagnostics Center Company Information
  45. 8.8.2 DNA Diagnostics Center Business Overview
  46. 8.8.3 DNA Diagnostics Center Direct-to-consumer Genetic Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 DNA Diagnostics Center Direct-to-consumer Genetic Testing Product Portfolio
  48. 8.8.5 DNA Diagnostics Center Recent Developments
  49. 8.9 Invitae
  50. 8.9.1 Invitae Company Information
  51. 8.9.2 Invitae Business Overview
  52. 8.9.3 Invitae Direct-to-consumer Genetic Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Invitae Direct-to-consumer Genetic Testing Product Portfolio
  54. 8.9.5 Invitae Recent Developments
  55. 8.10 IntelliGenetics
  56. 8.10.1 IntelliGenetics Company Information
  57. 8.10.2 IntelliGenetics Business Overview
  58. 8.10.3 IntelliGenetics Direct-to-consumer Genetic Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 IntelliGenetics Direct-to-consumer Genetic Testing Product Portfolio
  60. 8.10.5 IntelliGenetics Recent Developments
  61. 8.11 Ambry Genetics
  62. 8.11.1 Ambry Genetics Company Information
  63. 8.11.2 Ambry Genetics Business Overview
  64. 8.11.3 Ambry Genetics Direct-to-consumer Genetic Testing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Ambry Genetics Direct-to-consumer Genetic Testing Product Portfolio
  66. 8.11.5 Ambry Genetics Recent Developments
  67. 8.12 Living DNA
  68. 8.12.1 Living DNA Company Information
  69. 8.12.2 Living DNA Business Overview
  70. 8.12.3 Living DNA Direct-to-consumer Genetic Testing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Living DNA Direct-to-consumer Genetic Testing Product Portfolio
  72. 8.12.5 Living DNA Recent Developments
  73. 8.13 EasyDNA
  74. 8.13.1 EasyDNA Company Information
  75. 8.13.2 EasyDNA Business Overview
  76. 8.13.3 EasyDNA Direct-to-consumer Genetic Testing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 EasyDNA Direct-to-consumer Genetic Testing Product Portfolio
  78. 8.13.5 EasyDNA Recent Developments
  79. 8.14 Pathway Genomics
  80. 8.14.1 Pathway Genomics Company Information
  81. 8.14.2 Pathway Genomics Business Overview
  82. 8.14.3 Pathway Genomics Direct-to-consumer Genetic Testing Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Pathway Genomics Direct-to-consumer Genetic Testing Product Portfolio
  84. 8.14.5 Pathway Genomics Recent Developments
  85. 8.15 Centrillion Technology
  86. 8.15.1 Centrillion Technology Company Information
  87. 8.15.2 Centrillion Technology Business Overview
  88. 8.15.3 Centrillion Technology Direct-to-consumer Genetic Testing Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Centrillion Technology Direct-to-consumer Genetic Testing Product Portfolio
  90. 8.15.5 Centrillion Technology Recent Developments
  91. 8.16 Xcode
  92. 8.16.1 Xcode Company Information
  93. 8.16.2 Xcode Business Overview
  94. 8.16.3 Xcode Direct-to-consumer Genetic Testing Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Xcode Direct-to-consumer Genetic Testing Product Portfolio
  96. 8.16.5 Xcode Recent Developments
  97. 8.17 Color Genomics
  98. 8.17.1 Color Genomics Company Information
  99. 8.17.2 Color Genomics Business Overview
  100. 8.17.3 Color Genomics Direct-to-consumer Genetic Testing Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Color Genomics Direct-to-consumer Genetic Testing Product Portfolio
  102. 8.17.5 Color Genomics Recent Developments
  103. 8.18 Anglia DNA Services
  104. 8.18.1 Anglia DNA Services Company Information
  105. 8.18.2 Anglia DNA Services Business Overview
  106. 8.18.3 Anglia DNA Services Direct-to-consumer Genetic Testing Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Anglia DNA Services Direct-to-consumer Genetic Testing Product Portfolio
  108. 8.18.5 Anglia DNA Services Recent Developments
  109. 8.19 African Ancestry
  110. 8.19.1 African Ancestry Company Information
  111. 8.19.2 African Ancestry Business Overview
  112. 8.19.3 African Ancestry Direct-to-consumer Genetic Testing Revenue and Gross Margin (2021-2026)
  113. 8.19.4 African Ancestry Direct-to-consumer Genetic Testing Product Portfolio
  114. 8.19.5 African Ancestry Recent Developments
  115. 8.20 Canadian DNA Services
  116. 8.20.1 Canadian DNA Services Company Information
  117. 8.20.2 Canadian DNA Services Business Overview
  118. 8.20.3 Canadian DNA Services Direct-to-consumer Genetic Testing Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Canadian DNA Services Direct-to-consumer Genetic Testing Product Portfolio
  120. 8.20.5 Canadian DNA Services Recent Developments
  121. 8.21 DNA Family Check
  122. 8.21.1 DNA Family Check Company Information
  123. 8.21.2 DNA Family Check Business Overview
  124. 8.21.3 DNA Family Check Direct-to-consumer Genetic Testing Revenue and Gross Margin (2021-2026)
  125. 8.21.4 DNA Family Check Direct-to-consumer Genetic Testing Product Portfolio
  126. 8.21.5 DNA Family Check Recent Developments
  127. 8.22 Alpha Biolaboratories
  128. 8.22.1 Alpha Biolaboratories Company Information
  129. 8.22.2 Alpha Biolaboratories Business Overview
  130. 8.22.3 Alpha Biolaboratories Direct-to-consumer Genetic Testing Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Alpha Biolaboratories Direct-to-consumer Genetic Testing Product Portfolio
  132. 8.22.5 Alpha Biolaboratories Recent Developments
  133. 8.23 Test Me DNA
  134. 8.23.1 Test Me DNA Company Information
  135. 8.23.2 Test Me DNA Business Overview
  136. 8.23.3 Test Me DNA Direct-to-consumer Genetic Testing Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Test Me DNA Direct-to-consumer Genetic Testing Product Portfolio
  138. 8.23.5 Test Me DNA Recent Developments
  139. 8.24 23 Mofang
  140. 8.24.1 23 Mofang Company Information
  141. 8.24.2 23 Mofang Business Overview
  142. 8.24.3 23 Mofang Direct-to-consumer Genetic Testing Revenue and Gross Margin (2021-2026)
  143. 8.24.4 23 Mofang Direct-to-consumer Genetic Testing Product Portfolio
  144. 8.24.5 23 Mofang Recent Developments
  145. 8.25 Genetic Health
  146. 8.25.1 Genetic Health Company Information
  147. 8.25.2 Genetic Health Business Overview
  148. 8.25.3 Genetic Health Direct-to-consumer Genetic Testing Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Genetic Health Direct-to-consumer Genetic Testing Product Portfolio
  150. 8.25.5 Genetic Health Recent Developments
  151. 8.26 DNA Services of America
  152. 8.26.1 DNA Services of America Company Information
  153. 8.26.2 DNA Services of America Business Overview
  154. 8.26.3 DNA Services of America Direct-to-consumer Genetic Testing Revenue and Gross Margin (2021-2026)
  155. 8.26.4 DNA Services of America Direct-to-consumer Genetic Testing Product Portfolio
  156. 8.26.5 DNA Services of America Recent Developments
  157. 8.27 Shuwen Health Sciences
  158. 8.27.1 Shuwen Health Sciences Company Information
  159. 8.27.2 Shuwen Health Sciences Business Overview
  160. 8.27.3 Shuwen Health Sciences Direct-to-consumer Genetic Testing Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Shuwen Health Sciences Direct-to-consumer Genetic Testing Product Portfolio
  162. 8.27.5 Shuwen Health Sciences Recent Developments
  163. 8.28 Mapmygenome
  164. 8.28.1 Mapmygenome Company Information
  165. 8.28.2 Mapmygenome Business Overview
  166. 8.28.3 Mapmygenome Direct-to-consumer Genetic Testing Revenue and Gross Margin (2021-2026)
  167. 8.28.4 Mapmygenome Direct-to-consumer Genetic Testing Product Portfolio
  168. 8.28.5 Mapmygenome Recent Developments
  169. 8.29 Full Genomes
  170. 8.29.1 Full Genomes Company Information
  171. 8.29.2 Full Genomes Business Overview
  172. 8.29.3 Full Genomes Direct-to-consumer Genetic Testing Revenue and Gross Margin (2021-2026)
  173. 8.29.4 Full Genomes Direct-to-consumer Genetic Testing Product Portfolio
  174. 8.29.5 Full Genomes Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst